Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 50, 7587-7592, December 1, 1990]
© 1990 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nara, N.
Right arrow Articles by Tomiyama, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nara, N.
Right arrow Articles by Tomiyama, J.

Effects of N4-Behenoyl-1-ß-D-Arabinofuranosylcytosine on Blast Progenitors of Acute Myeloblastic Leukemia1

Nobuo Nara2, Shuji Tohda, Toshiya Suzuki, Kaoru Nagata, Yoko Yamashita, Yasufumi Imai, Yasuo Maruyama and Junji Tomiyama

Departments of Laboratory Medicine [N. N.] and Internal Medicine 1 [S. T., T. S., K. N., Y. Y., Y. I.], Tokyo Medical and Dental University, Yushima I-5-45, Bunkyo-Ku, Tokyo 113; Tokyo Metropolitan Komagome Hospital, Honkomagome 3-18-22, Bunkyo-Ku, Tokyo 113 [Y. M.]; and Tokyo Metropolitan Bokuto Hospital, Koutoubashi 4-23-15, Sumida-Ku, Tokyo 130 [J. T.], Japan

To determine the antileukemic effect of N4-behenoyl-1-ß-D-arabinofuranosylcytosine (BH-AC), a synthetic masked compound of 1-ß-D-arabinofuranosylcytosine, the pharmacokinetics and suppressive effect on leukemic blast progenitors of BH-AC were studied. When BH-AC was added to the suspension culture of leukemic cells, BH-AC gradually decreased in concentration in the culture media and was rapidly taken into the cellular fraction. The conversion from BH-AC to 1-ß-D-arabinofuranosylcytosine was noted in both the culture media and the cellular fraction. The concentration of 1-ß-D-arabinofuranosylcytosine converted from BH-AC in the culture medium gradually increased during 7 days of culture, although the rate of conversion was variable among the samples.

BH-AC suppressed primary and secondary blast colony formation in a dose responsive manner. BH-AC also suppressed the recovery of clonogenic cells in suspension culture. The suppression by BH-AC was more prominent in secondary blast colony formation and the recovery of clonogenic cells in suspension culture than in primary blast colony formation. Secondary blast colony formation and the recovery of clonogenic cells in suspension are considered to reflect the self-renewal of blast progenitors, while primary blast colony formation is considered to reflect the terminal divisions of blast progenitors. The results obtained in the present study suggest that BH-AC is more effective to suppress the self-renewal of blast progenitors than the terminal divisions. The findings offer a theoretical basis in the utility of BH-AC in the therapy of acute myeloblastic leukemia.

1 Supported in part by a Grant-in-aid for Scientific Research from the Ministry of Education, Science and Culture, Japan.

2 To whom requests for reprints should be addressed.

Received 6/25/90. Accepted 9/ 5/90.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1990 by the American Association for Cancer Research.